Drug Trial Radar · NCT06949124
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Sep 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Apr 28, 2025
Primary completion
Jun 5, 2025
Study completion Jun 5, 2025
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effects of SHR7280 on the pharmacokinetics of midazolam, S-warfarin, omeprazole, digoxin and rosuvastatin in healthy subjects.
Conditions
- Endometriosis
- Uterine Fibroids
- Assisted Reproduction
Interventions
SHR7280 TabletsDrug
SHR7280 tablets.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum concentration (Cmax)Time frame: 0 to anticipated 29 days.
- Area under the curve from time 0 to infinity (AUC0-∞)Time frame: 0 to anticipated 29 days.
- Area under the curve from time 0 to time t (AUC0-t)Time frame: 0 to anticipated 29 days.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Zhongnan hospital of Wuhan University
Wuhan, Hubei, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.